Immunome, Inc.

IMNM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$143,351$98,679$20,323$49,229
Short-Term Investments$73,952$39,463$0$0
Receivables$0$289$847$4,312
Inventory$0$0$0$0
Other Curr. Assets$4,036$6,272$1,479$3,097
Total Curr. Assets$221,339$144,703$22,649$56,638
Property Plant & Equip (Net)$14,391$3,637$965$855
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$100$0$100
Tax Assets$0$0$0$0
Other NC Assets$4,511$100$432$332
Total NC Assets$18,902$3,837$1,397$1,287
Other Assets$0$0$0$0
Total Assets$240,241$148,540$24,046$57,925
Liabilities
Payables$14,189$3,311$2,400$3,077
Short-Term Debt$63$310$229$317
Tax Payable$0$0$0$0
Deferred Revenue$6,941$10,493$0$0
Other Curr. Liab.$33,114$7,715$4,702$6,334
Total Curr. Liab.$54,307$21,829$7,331$9,728
LT Debt$4,769$1,340$62$0
Deferred Rev, NC$0$5,489$0$0
Deferred Tax Liab, NC$0-$5,489$0$0
Other NC Liab.$0$5,489$0$12
Total NC Liab.$4,769$6,829$62$12
Other Liabilities$0$0$0$0
Cap. Leases$4,832$1,650$291$317
Total Liabilities$59,076$28,658$7,393$9,740
Equity
Pref Stock$0$0$0$57,925
Common Stock$6$4$1$1
Retained Earnings-$515,770-$222,807-$116,001-$79,105
AOCI$57$22$0-$57,925
Other Equity$696,872$342,663$132,653$127,289
Total Equity$181,165$119,882$16,653$48,185
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$240,241$148,540$24,046$57,925
Net Debt-$138,519-$97,029-$20,032-$48,912